TELADOC HEALTH, INC. Cost of Revenue
TELADOC HEALTH, INC. (TDOC) reported Cost of Revenue of $190.54 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-07-28.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2023-07-28
- TELADOC HEALTH, INC. cost of goods and services sold for the quarter ending 2023-06-30 was $190.54M, a 4.42% increase year-over-year.
- TELADOC HEALTH, INC. cost of goods and services sold for the quarter ending 2023-03-31 was $190.11M, a 1.65% increase year-over-year.
- TELADOC HEALTH, INC. cost of goods and services sold for the quarter ending 2022-12-31 was $188.87M, a 7.94% increase year-over-year.
- TELADOC HEALTH, INC. cost of goods and services sold for the quarter ending 2022-09-30 was $185.62M, a 9.81% increase year-over-year.
- TELADOC HEALTH, INC. cost of goods and services sold for fiscal 2022 was $743.99M, a 14.41% increase from fiscal 2021.
- TELADOC HEALTH, INC. cost of goods and services sold for fiscal 2021 was $650.26M, a 66.38% increase from fiscal 2020.
- TELADOC HEALTH, INC. cost of goods and services sold for fiscal 2020 was $390.83M, a 111.87% increase from fiscal 2019.
- TELADOC HEALTH, INC. cost of goods and services sold for fiscal 2019 was $184.47M, a 43.29% increase from fiscal 2018.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2023-06-30 | $190.54M 10-Q · filed 2023-07-28 | $380.65M 10-Q · filed 2023-07-28 | $569.52M derived: sum of 3 quarters · filed 2023-07-28 | $755.14M derived: sum of 4 quarters · filed 2023-07-28 |
| 2023-03-31 | $190.11M 10-Q · filed 2023-05-02 | $378.98M derived: sum of 2 quarters · filed 2023-05-02 | $564.60M derived: sum of 3 quarters · filed 2023-05-02 | $747.07M derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-12-31 | $188.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $374.49M derived: sum of 2 quarters · filed 2023-03-01 | $556.96M derived: sum of 3 quarters · filed 2023-07-28 | $743.99M 10-K · filed 2023-03-01 |
| 2022-09-30 | $185.62M 10-Q · filed 2022-11-02 | $368.09M derived: sum of 2 quarters · filed 2023-07-28 | $555.11M 10-Q · filed 2022-11-02 | $730.10M derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-06-30 | $182.47M 10-Q · filed 2023-07-28 | $369.50M 10-Q · filed 2023-07-28 | $544.48M derived: sum of 3 quarters · filed 2023-07-28 | $713.52M derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-03-31 | $187.03M 10-Q · filed 2023-05-02 | $362.01M derived: sum of 2 quarters · filed 2023-05-02 | $531.05M derived: sum of 3 quarters · filed 2023-05-02 | $691.32M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $174.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $344.03M derived: sum of 2 quarters · filed 2023-03-01 | $504.30M derived: sum of 3 quarters · filed 2023-03-01 | $650.26M 10-K · filed 2023-03-01 |
| 2021-09-30 | $169.04M 10-Q · filed 2022-11-02 | $329.31M derived: sum of 2 quarters · filed 2022-11-02 | $475.27M 10-Q · filed 2022-11-02 | $598.22M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $160.27M 10-Q · filed 2022-08-03 | $306.23M 10-Q · filed 2022-08-03 | $429.17M derived: sum of 3 quarters · filed 2023-03-01 | $533.90M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $145.96M 10-Q · filed 2022-05-02 | $268.90M derived: sum of 2 quarters · filed 2023-03-01 | $373.63M derived: sum of 3 quarters · filed 2023-03-01 | $464.41M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $122.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $227.67M derived: sum of 2 quarters · filed 2023-03-01 | $318.45M derived: sum of 3 quarters · filed 2023-03-01 | $390.83M 10-K · filed 2023-03-01 |
| 2020-09-30 | $104.72M 10-Q · filed 2021-11-01 | $195.50M derived: sum of 2 quarters · filed 2021-11-01 | $267.89M 10-Q · filed 2021-11-01 | $323.24M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $90.78M 10-Q · filed 2021-08-02 | $163.16M 10-Q · filed 2021-08-02 | $218.52M derived: sum of 3 quarters · filed 2021-08-02 | $261.32M derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | $72.38M 10-Q · filed 2021-05-03 | $127.74M derived: sum of 2 quarters · filed 2021-05-03 | $170.54M derived: sum of 3 quarters · filed 2021-05-03 | $212.17M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $55.35M 10-K · filed 2020-02-26 | $98.15M derived: sum of 2 quarters · filed 2020-11-06 | $139.79M derived: sum of 3 quarters · filed 2020-11-06 | $184.47M 10-K · filed 2022-02-28 |
| 2019-09-30 | $42.80M 10-Q · filed 2020-11-06 | $84.43M derived: sum of 2 quarters · filed 2020-11-06 | $129.11M 10-Q · filed 2020-11-06 | $169.14M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $41.63M 10-Q · filed 2020-07-29 | $86.31M 10-Q · filed 2020-07-29 | $126.34M derived: sum of 3 quarters · filed 2020-07-29 | $160.51M derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $44.68M 10-Q · filed 2020-04-29 | $84.70M derived: sum of 2 quarters · filed 2020-04-29 | $118.87M derived: sum of 3 quarters · filed 2020-04-29 | $146.56M derived: sum of 4 quarters · filed 2020-04-29 |
| 2018-12-31 | $40.03M 10-K · filed 2020-02-26 | $74.19M derived: sum of 2 quarters · filed 2020-02-26 | $101.88M derived: sum of 3 quarters · filed 2020-02-26 | $128.74M 10-K · filed 2021-03-01 |
| 2018-09-30 | $34.17M 10-K · filed 2020-02-26 | $61.85M derived: sum of 2 quarters · filed 2020-02-26 | $88.71M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $27.68M 10-K · filed 2020-02-26 | $54.54M 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | $26.86M 10-K · filed 2020-02-26 | |||
| 2017-12-31 | $61.62M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |